Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ROCHE HOLDING AG

(ROG)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur ROCHE HOLDING AG
24/10Presseschau vom Wochenende 41 (23./24. Oktober)
22/10Roche's implant for chronic eye disorder wins U.S. approval
22/10WDH : Roche erhält US-Zulassung für Augenimplantat Susvimo
22/10ROCHE : eye implant wins FDA approval
22/10ROCHE : FDA Approves Genentech's Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet..
22/10ROCHE : FDA approves Roche's Susvimo, a first-of-its-kind therapeutic approach for neovasc..
22/10PRESS RELEASE : FDA approves Roche's Susvimo, a -2-
22/10PRESS RELEASE : FDA approves Roche's Susvimo, a first-of-its-kind therapeutic approach for..
22/10Roche Announces FDA Approves its Susvimo, Therapeutic Approach for Neovascular or Wet A..
22/10COVID : Comm.Ue definisce portafoglio delle 10 cure più promettenti
22/10Lymphoma Hub maintains its focus on raising the levels of global knowledge of lymphoma ..
22/10Roche erhält grünes Licht von FDA für Krebstest
22/10ROCHE : Wins US FDA Nod For VENTANA Test In Non-Small Cell Lung Cancer Patients
22/10ROCHE : VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to ide..
22/10PRESS RELEASE : Roche's VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion d..
22/10Roche?s VENTANA PD-L1 Assay Receives FDA Approval as a Companion Diagnostic to Identify..
21/10Aktien Schweiz gut behauptet - Prognosesenkung lässt ABB einbrechen
21/10CHUGAI PHARMACEUTICAL : Contribution of Para-transit Vehicles to Welfare Services
21/10ROCHE : Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Third Quarter Sal..
20/10MÄRKTE EUROPA/Konsolidierung - Weidmann-Rücktritt ohne Impuls
20/10Aktien Schweiz freundlich - Nestle nach Zahlenvorlage sehr fest
20/10MÄRKTE EUROPA/Anleger werden moderat vorsichtiger
20/10Pharmakonzern Roche hebt Umsatzziel an - Corona-Geschäfte laufen gut
20/10MIDDAY BRIEFING - Unternehmen und Märkte -2-
20/10MÄRKTE EUROPA/Seitwärts - Weidmann tritt zurück
20/10OLEG DERIPASKA : Stocks Drift as -2-
20/10Für Roche wird Corona-Geschäft zum Wachstumstreiber
20/10Roche-Bons neigen nach Zahlen etwas zur Schwäche
20/10European stocks hit 6-week highs as Nestle shines in mixed bag of earnings
20/10ROCHE : Forecasts Dividend Hike As Third-Quarter Sales Surge on High COVID-19 Test Demand
20/10ROCHE : Arzneimittel-Verkäufe erholen sich - Roche hebt Prognose an
20/10OPINIONES DE LOS ANALISTAS DEL DÍA : Endesa, Flatexdegiro, Netflix, Kering, Lonza, Philips..
20/10MÄRKTE EUROPA/Wenig verändert - Flut von Unternehmenszahlen
20/10Donde todo es cuestión de resultados empresariales, bitcoin y metavers
20/10ROCHE : Nine-month 2021 Investor update
20/10MÄRKTE EUROPA/Wenig verändert erwartet - Zahlen und Inflation im Blick
20/10Roche lässt mit erhöhter Jahresprognose Coronakrise hinter sich
20/10Roche hebt wegen anhaltend starker Diagnostik Prognose an
20/10ROCHE : Q3 Sales Jump 8% on New Medicines Growth; FY Sales Guidance Raised
20/10ROCHE : expects higher 2021 sales as Delta spurs COVID-19 tests
20/10ROCHE : raises 2021 outlook as COVID-19 tests continue powering sales
20/10ROCHE : mit starkem Wachstum in den ersten neun Monaten 2021 – Ausblick für das Gesa..
20/10ROCHE : reports strong growth in the first nine months – outlook for 2021 raised - I..
20/10ROCHE : Nine-month 2021 Presentation without appendix
20/10ROCHE : Nine-month 2021 Presentation with appendix
20/10Roche hebt dank gutem Wachstum Jahresprognose leicht an
20/10ROCHE : reports strong growth in the first nine months – outlook for 2021 raised
20/10Roche 3Q Sales Grew; Raises Outlook
19/10ADRs End Higher; Ericsson, Danone Among Companies Actively Trading
19/10Wall Street rises as investors bet on positive earnings season
19/10Health Care Up Sharply After Strong J&J Earnings -- Health Care Roundup
19/10ATEA PHARMACEUTICALS : Shares Plunge After COVID-19 Pill Candidate Misses Phase 2 Primary ..
19/10Aktien Schweiz knapp behauptet - Nestle und Roche belasten SMI
19/10Atea plunges after COVID-19 treatment fails to help patients in study
19/10Atea se desploma tras un estudio que no muestra eficacia en su tratamiento del COVID
19/10ROCHE : Atea Pharmaceuticals COVID-19 Drug Fails To Meet Phase Two Endpoint
19/10AUSBLICK ROCHE : Umsatz von 46,5 Mrd Franken nach 9 Monaten erwartet
19/10Roche-Partner Atea erreicht Ziele in Studie mit Corona-Pille nicht
19/10Atea Shares Fall 75% After Covid-19 Trial Misses Objective
19/10Atea's Covid-19 Trial Misses Objective in Overall Patient Population
19/10European stocks rise as defensive buying helps offset losses on downbeat earnings
18/10GLOBAL MARKETS LIVE : Valneva, Glencore, Facebook, Roche, Hertz...
18/10TODAY ON WALL STREET : This is the real test
18/10La feria de resultados vuelve a estar en pleno apogeo
18/10Roche baut technologische Innovation in Pathologie mit Ibex-Zusammenarbeit aus
18/10Roche Announces Collaboration with Ibex Medical Analytics to Develop Artificial Intelli..
18/10ROCHE : Heirs to Shut Down Philanthropic Foundation Focused on Nature Conservation
18/10ROCHE : Wins US FDA Nod For Non-Small Cell Lung Cancer Therapy Tecentriq
17/10ROCHE : family shareholders will maintain stability - vice chairman
15/10ROCHE : FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With E..
15/10ROCHE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with ea..
15/10PRESS RELEASE : US FDA approves Roche's Tecentriq -2-
15/10PRESS RELEASE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people..
15/10US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Certain People with Early N..
15/10ROCHE : FDA erteilt Zulassung für Tecentriq bei nicht-kleinzelligem Lungenkrebs
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur ROCHE HOLDING AG